Why the 6% drop today - with no news, page-43

One of issue on AC8 is it does not have actual control on research development, it all relies on the JV and partnership, itself sounds more like a drug reseller rather than an actual R&D company. This has a big risky to investors, what if AC8's key prioritized objective does not fit to the prioritize of its partners? Other real concern is the CEO of AC8, the daughter and father, are both basically avocado farmers and have no knowledge on either growing or cannabis medicine, and to me how this going to work is a myth.